US Stock MarketDetailed Quotes

SRPT Sarepta Therapeutics

Watchlist
  • 145.610
  • +1.830+1.27%
Close Jul 19 16:00 ET
  • 145.610
  • 0.0000.00%
Pre 07:28 ET
13.76BMarket Cap338.63P/E (TTM)

Sarepta Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sarepta Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 1, 2024

Revenue(YoY)

413.46M

+63.10%
EPS(YoY)

0.37

+106.31%
Analyst Rating

Strong Buy

Jun 30, 2024

Sarepta Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 537.404M--
--2024/Q2-- / 393.536M--
May 1, 20242024/Q1413.464M / 375.429M--
Feb 28, 20242023/Q4396.781M / 386.164M--
Nov 1, 20232023/Q3331.817M / 286.773M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 537.404M--
--2024/Q2-- / 393.536M--
May 1, 20242024/Q1413.464M / 375.429M--
Feb 28, 20242023/Q4396.781M / 386.164M--
Nov 1, 20232023/Q3331.817M / 286.773M--

Unlock Free Earnings Estimates

Sarepta Therapeutics Earnings Reports

  • Sarepta Therapeutics | 10-Q: Quarterly report

    May 1 16:07 ET

  • Sarepta Therapeutics | 10-K: Annual report

    Feb 28 16:11 ET

  • Sarepta Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 1, 2023 16:01 ET

  • Sarepta Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 16:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg